Literature DB >> 23467368

Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: effects of alcoholism.

Nora D Volkow1, Dardo Tomasi, Gene-Jack Wang, Frank Telang, Joanna S Fowler, Jean Logan, L Jayne Maynard, Christopher T Wong.   

Abstract

Dopamine signals through D1-like and D2-like receptors, which can stimulate or inhibit, respectively, neuronal activity. Here we assessed the balance between D1 or D2 receptor signaling in the human brain and how it is affected in alcoholism. Using PET, we measured the relationship between changes in dopamine and brain glucose metabolism induced by methylphenidate in controls and alcoholics. We show that methylphenidate induced significant DA increases in striatum, amygdala, and medial orbitofrontal cortex, whereas it decreased metabolism in these brain regions. Methylphenidate-induced dopamine increases were greater in controls than in alcoholics, whereas methylphenidate-induced metabolic decreases were greater in alcoholics. For both groups, methylphenidate-induced dopamine increases were associated with decreases in regional brain metabolism, and the correlations were strongest in subthalamic nuclei, anterior cingulate, and medial orbitofrontal cortex. These correlations were more extensive and robust and the slopes steeper in alcoholics than in controls despite their attenuated dopamine responses to methylphenidate, which suggests an impaired modulation of dopamine signals in the brain of alcoholic subjects. These findings are consistent with a predominant inhibitory effect of dopamine in the human brain that is likely mediated by the prominence of dopamine D2/D3 receptors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467368      PMCID: PMC3732804          DOI: 10.1523/JNEUROSCI.5261-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.

Authors:  Anthony R West; Anthony A Grace
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge.

Authors:  Paul R A Stokes; Alice Egerton; Ben Watson; Alistair Reid; Gerome Breen; Anne Lingford-Hughes; David J Nutt; Mitul A Mehta
Journal:  Neuroimage       Date:  2010-05-06       Impact factor: 6.556

3.  Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex.

Authors:  Natalia Gorelova; Jeremy K Seamans; Charles R Yang
Journal:  J Neurophysiol       Date:  2002-12       Impact factor: 2.714

4.  Parcellations and hemispheric asymmetries of human cerebral cortex analyzed on surface-based atlases.

Authors:  David C Van Essen; Matthew F Glasser; Donna L Dierker; John Harwell; Timothy Coalson
Journal:  Cereb Cortex       Date:  2011-11-02       Impact factor: 5.357

5.  Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Jean Logan; Dinko Franceschi; Laurence Maynard; Yu-Shin Ding; Samuel J Gatley; Andrew Gifford; Wei Zhu; James M Swanson
Journal:  Synapse       Date:  2002-03-01       Impact factor: 2.562

Review 6.  Addiction circuitry in the human brain.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Dardo Tomasi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-27       Impact factor: 13.820

7.  Dopaminergic mechanisms of individual differences in human effort-based decision-making.

Authors:  Michael T Treadway; Joshua W Buckholtz; Ronald L Cowan; Neil D Woodward; Rui Li; M Sib Ansari; Ronald M Baldwin; Ashley N Schwartzman; Robert M Kessler; David H Zald
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

8.  Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.

Authors:  Paul Shotbolt; Andri C Tziortzi; Graham E Searle; Alessandro Colasanti; Jasper van der Aart; Sergio Abanades; Christophe Plisson; Sam R Miller; Mickael Huiban; John D Beaver; Roger N Gunn; Marc Laruelle; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-31       Impact factor: 6.200

9.  Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.

Authors:  Marios Politis; Nicola Pavese; Yen F Tai; Lorenzo Kiferle; Sarah L Mason; David J Brooks; Sarah J Tabrizi; Roger A Barker; Paola Piccini
Journal:  Hum Brain Mapp       Date:  2011-02       Impact factor: 5.038

10.  Decreased dopamine activity predicts relapse in methamphetamine abusers.

Authors:  G J Wang; L Smith; N D Volkow; F Telang; J Logan; D Tomasi; C T Wong; W Hoffman; M Jayne; N Alia-Klein; P Thanos; J S Fowler
Journal:  Mol Psychiatry       Date:  2011-07-12       Impact factor: 15.992

View more
  17 in total

1.  Brain activation and neurochemistry.

Authors:  Dardo Tomasi; Nora D Volkow
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-19       Impact factor: 11.205

2.  [DSM-5: important changes in the field of addictive diseases].

Authors:  A Heinz; E Friedel
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

Review 3.  Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.

Authors:  Nora L Nock; Sonia Minnes; Jay L Alberts
Journal:  Birth Defects Res       Date:  2017-12-01       Impact factor: 2.344

4.  DRD2 promoter methylation and measures of alcohol reward: functional activation of reward circuits and clinical severity.

Authors:  L Cinnamon Bidwell; Hollis C Karoly; Rachel E Thayer; Eric D Claus; Angela D Bryan; Barbara J Weiland; Sophie YorkWilliams; Kent E Hutchison
Journal:  Addict Biol       Date:  2018-02-21       Impact factor: 4.280

5.  Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males.

Authors:  Corinde E Wiers; Ehsan Shokri-Kojori; Christopher T Wong; Anissa Abi-Dargham; Şükrü B Demiral; Dardo Tomasi; Gene-Jack Wang; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2016-05-09       Impact factor: 7.853

6.  BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology.

Authors:  Isabel Cubero-Millán; María-José Ruiz-Ramos; Antonio Molina-Carballo; Sylvia Martínez-Serrano; Luisa Fernández-López; Irene Machado-Casas; Pilar Tortosa-Pinto; Aida Ruiz-López; Juan-de-Dios Luna-Del-Castillo; José Uberos; Antonio Muñoz-Hoyos
Journal:  Psychopharmacology (Berl)       Date:  2016-11-03       Impact factor: 4.530

Review 7.  Reciprocal midbrain-extended amygdala circuit activity in preclinical models of alcohol use and misuse.

Authors:  Elizabeth M Avegno; Nicholas W Gilpin
Journal:  Neuropharmacology       Date:  2021-10-25       Impact factor: 5.250

8.  Early avoidance of a heroin-paired taste-cue and subsequent addiction-like behavior in rats.

Authors:  Christopher B Jenney; Jessica Petko; Brittany Ebersole; Christian V Nzinkeu Njatcha; Teddy O Uzamere; Danielle N Alexander; Patricia S Grigson; Robert Levenson
Journal:  Brain Res Bull       Date:  2015-10-19       Impact factor: 4.077

9.  Alcohol dependence activates ventral tegmental area projections to central amygdala in male mice and rats.

Authors:  Elizabeth M Avegno; Chelsea R Kasten; William B Snyder; Leslie K Kelley; Thomas D Lobell; Taylor J Templeton; Michael Constans; Tiffany A Wills; Jason W Middleton; Nicholas W Gilpin
Journal:  Addict Biol       Date:  2020-12-16       Impact factor: 4.280

10.  Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.

Authors:  Kenneth Blum; David Han; John Femino; David E Smith; Scott Saunders; Thomas Simpatico; Stephen J Schoenthaler; Marlene Oscar-Berman; Mark S Gold
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.